Skip to content

Apollonia - KNOL: what changed

BE 0695.503.856NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€16,870
2024 · €4,733-€21,604
Equity
€19,903
2024 · €36,774-€16,870
Cash
€10,330
2024 · €29,752-€19,422
Balance sheet total
€1.6m
2024 · €1.8m-€168,643

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€149,221

    down €149,221 (-8.4%), from €1.8m to €1.6m

    of which Trade receivables: -€151,102

  • Cash -€19,422

    down €19,422 (-65.3%), from €29,752 to €10,330

    mainly Accrued charges and deferred income (-€190,086) and Net result for the year (-€16,870)

Equity and liabilities
  • Accrued charges and deferred income -€190,086

    down €190,086 (-10.9%), from €1.7m to €1.6m

  • Trade debts +€38,278

    up €38,278 (+207%), from €18,493 to €56,771

Income statement
  • Financial charges +€20,030

    up €20,030 (+315%), from €6,362 to €26,392

    of which Non-recurring financial charges: +€20,050

  • Taxes +€13,271

    up €13,271 (+257%), from €5,170 to €18,441

  • Gross operating margin +€11,785

    up €11,785 (+68.4%), from €17,223 to €29,007

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €4,733
Gross operating margin +€11,785
Other operating charges -€31
Financial income -€56
Financial charges -€20,030
Taxes -€13,271
Result 2025 -€16,870
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€19,422
Investment €0
Financing €0
Cash 2024 €29,752
Net result for the year -€16,870
Receivables within one year +€149,221
Trade debts +€38,278
Smaller working-capital items +€35
Accrued charges and deferred income -€190,086
Cash 2025 €10,330
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,803,849 €1,635,206 -€168,643 -9.3%
Current assets 29/58 €1,803,849 €1,635,206 -€168,643 -9.3%
Amounts receivable within one year 40/41 €1,774,097 €1,624,876 -€149,221 -8.4%
Trade receivables 40 €1,774,097 €1,622,994 -€151,102 -8.5%
Other amounts receivable 41 - €1,881 +€1,881
Cash at bank and in hand 54/58 €29,752 €10,330 -€19,422 -65.3%
Total equity and liabilities 10/49 €1,803,849 €1,635,206 -€168,643 -9.3%
Equity 10/15 €36,774 €19,903 -€16,870 -45.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Profit (loss) carried forward 14 €18,174 €1,303 -€16,870 -92.8%
Amounts payable 17/49 €1,767,075 €1,615,302 -€151,773 -8.6%
Amounts payable within one year 42/48 €18,663 €56,976 +€38,313 +205%
Trade debts 44 €18,493 €56,771 +€38,278 +207%
Suppliers 440/4 €18,493 €56,771 +€38,278 +207%
Taxes, remuneration and social security 45 €170 - -€170
Taxes 450/3 €170 - -€170
Other amounts payable 47/48 - €206 +€206
Accrued charges and deferred income 492/3 €1,748,412 €1,558,326 -€190,086 -10.9%
Other operating charges 640/8 €1,155 €1,185 +€31 +2.7%
Gross operating margin 9900 €17,223 €29,007 +€11,785 +68.4%
Operating profit (loss) 9901 €16,068 €27,822 +€11,754 +73.1%
Financial income 75/76B €197 €141 -€56 -28.4%
Recurring financial income 75 €197 €141 -€56 -28.4%
Financial charges 65/66B €6,362 €26,392 +€20,030 +315%
Recurring financial charges 65 €222 €202 -€20 -9.0%
Non-recurring financial charges 66B €6,140 €26,190 +€20,050 +327%
Profit (loss) for the period before taxes 9903 €9,903 €1,571 -€8,332 -84.1%
Income taxes 67/77 €5,170 €18,441 +€13,271 +257%
Profit (loss) for the period 9904 €4,733 -€16,870 -€21,604
Profit (loss) for the period to be appropriated 9905 €4,733 -€16,870 -€21,604

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€56,284 to €74,817

Midpoint €64,006 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €19,903
Capitalised earnings €92,664 to €129,730
Indication €56,284 to €74,817

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€19,903
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€19,903

Capitalised earnings

net result for the year (9904)
2025
-€16,870
excluding non-recurring income and charges
€9,320
2024
€4,733
excluding non-recurring income and charges
€10,873
2023
€10,826
excluding non-recurring income and charges
€18,726
2022
€6,551
excluding non-recurring income and charges
€10,466
2021
€64
excluding non-recurring income and charges
€5,834
Average result, excluding non-recurring income and charges
€12,973
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€92,664 / €108,108 / €129,730

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.